Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on TrivarX.
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX swings wildly, Scentre drags and these assets could Trump bump
News
ASX Small Caps Lunch Wrap: Sigma-Chemist merge a done deal; Quickstep kicks up 95pc
Health & Biotech
Health Check: Neuren’s ‘Willy Wonka’ voucher shows how a piece of paper can be worth US$50m
Health & Biotech
Health Kick Podcast: TrivarX hones the connection between sleep and depression
Health & Biotech
TrivarX seeks FDA meeting to advance trial of AI-based depression-screening tech
Health & Biotech
TrivarX’s AI is screening for depression by monitoring sleep
Health & Biotech
Wake Up! Don’t get caught sleeping on these three dreamy stocks
Health & Biotech
Diagnosing Depression in Your Sleep: TrivarX delivers positive Phase 2 study results
News
Rise and Shine: Everything you need to know before the ASX opens
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Diagnosing mental disorder through sleep: How TrivarX could capture this huge research market
Health & Biotech
ASX Health Stocks: Paradigm takes another step forward as Phase 2 trial meets primary endpoint
Health & Biotech
ASX Health Stocks: Radiopharm’s results published; ProMedicus launches on Apple Vision Pro
Health & Biotech
